Trials / Recruiting
RecruitingNCT05209568
Immune Responses to Gluten
Changes in Serum IL-2 Levels Following a Single Oral Dose of Gluten
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Boston Children's Hospital · Academic / Other
- Sex
- All
- Age
- 2 Years – 101 Years
- Healthy volunteers
- Accepted
Summary
This is a study of immune responses after eating gluten powder in people with celiac disease and healthy controls.
Detailed description
This is a multi-site open-label single dose gluten challenge study. Participants will provide a blood sample for measurement of cytokines before and 4 hours after eating gluten powder.
Conditions
- Celiac Disease
- Malabsorption Syndromes
- Digestive System Disease
- Intestinal Disease
- Gastrointestinal Diseases
- Gluten Sensitivity
- Celiac Disease in Children
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Gluten Powder | Single oral dose of gluten powder |
Timeline
- Start date
- 2023-01-15
- Primary completion
- 2028-09-30
- Completion
- 2029-09-30
- First posted
- 2022-01-26
- Last updated
- 2025-04-23
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05209568. Inclusion in this directory is not an endorsement.